Product Introduction:
Xilia Trio SR Tablet combines three antidiabetic agents—Glimepiride, Metformin, and Glimenclamide—in a sustained-release formulation for prolonged blood sugar control. This combination acts by increasing insulin secretion, enhancing insulin sensitivity, and decreasing hepatic glucose production.
Uses:
-
Treatment of type 2 diabetes mellitus
-
Helps in maintaining optimal blood glucose levels
-
Used alongside diet and exercise for diabetes management
Benefits:
-
Sustained-release ensures steady drug levels and better compliance
-
Provides comprehensive blood sugar control with multiple mechanisms
-
Helps reduce risk of diabetic complications
-
Convenient once or twice daily dosing
Composition:
-
Glimepiride – 0.2 mg
-
Metformin – 500 mg
-
Glimenclamide – 2 mg
Side Effects:
-
Hypoglycemia (low blood sugar)
-
Gastrointestinal upset (nausea, diarrhea)
-
Dizziness and headache
-
Weight gain
-
Allergic reactions (rare)
(Seek medical advice if side effects persist or worsen.)
Safety Advice:
-
Take with food to minimize stomach upset
-
Monitor blood glucose regularly
-
Avoid alcohol consumption
-
Inform your healthcare provider about other medications you use
-
Store in a cool, dry place away from direct sunlight
